Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

ressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, expected liquidity or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our transition report on Form 10-K for the six month period ended December 31, 2012 and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law.

 Pharmacyclics, Inc.Condensed Consolidated Balance Sheets(unaudited; in thousands)Mar. 31,Dec. 31,20
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Radiology information system ... used to store, manipulate, and distribute patient radiological ... tracking and scheduling system, result reporting, and an ... HIS and other databases improves the hospital workflow. ... scheduling, patient list management, radiology department workflow management, ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  Sage ... new generation of equipment for the testing of ... release of the new Luminary™ Profiler, the industry,s ... light-based measurement in a cost-effective, portable unit. ... the specific needs of the cannabis industry, the ...
(Date:12/19/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year 2015 results on Thursday, January 22, 2015, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2ResMed To Announce Second Quarter 2015 Results 2
... Androgen Deprivation and, Chemotherapy Reduced Size of Formerly Resistant Tumors ... Confirm Bavituximab,s Potential to Enhance Multiple ... Combination Regimens for Cancer Therapy -, ATLANTA, and TUSTIN, ... a clinical stage,biopharmaceutical company developing targeted monoclonal antibodies for the,treatment ...
... to More Effective Antibiotics Against ,Superbugs, BOSTON, ... of Engineering may have discovered the path,toward developing ... have developed resistance to common antibiotics. The,researchers have ... bacteria that opens to door to new avenues ...
Cached Medicine Technology:Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 2Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 3Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 4Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3
(Date:12/19/2014)... Albuquerque, New Mexico (PRWEB) December 19, 2014 ... pain relief industry is excited to announce a new ... gauss rare earth magnets. These are the strongest neodymium ... therapy necklace. Pain Free Living developed the Superior Magnetics ... magnets. , “Pain Free Living performs magnetic therapy using ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 From November 24, ... teacher training for the year 2014 in its Goa ... this year. Through the Indian winters, from November to March, ... the beautiful beach of Arambol, Goa. The Goa training sessions ... previous intakes of yoga teacher training, the 10th intake is ...
(Date:12/19/2014)... After a 13-year absence from active touring, ... the stage to entertain his many worldwide fans. Trisha ... the successful tour has been steadily expanding since the ... Ticketability.com for a large inventory of Garth ... prices. , Music fans have had a long wait ...
(Date:12/19/2014)... 2014 Consilium Staffing, Your Partner ... Society for Federal Health Professionals annual meeting in ... to military and federal healthcare providers. , ... Small Business Engagement (NVSBE) conference last week in ... a vital solution in addressing our nation’s shortage ...
(Date:12/19/2014)... 2014 (HealthDay News) -- Being in good shape seems to ... They looked at data from more than 57,000 Americans, including ... tests between 1991 and 2009. Those in the poorest ... high blood pressure at the start of the study, compared ... of fitness. Of the more than 8,000 people diagnosed ...
Breaking Medicine News(10 mins):Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Being Fit Keeps Blood Pressure in Check 2
... Sept. 5 Edwards Lifesciences,Corporation (NYSE: EW ... heart valves,today announced that it has received CE ... SAPIEN transcatheter aortic heart valve,technology with the RetroFlex ... heart valve is implanted via a,minimally-invasive procedure, without ...
... ALEXANDRIA, Va., Sept. 5 Traditional Latin,American foods have ... these foods that have brought families together for generations ... health. Oftentimes Latin foods are prepared with high-calorie ... According to the American Diabetes,Association (ADA), eating foods high ...
... Inc. (NYSE: WPI ), a leading specialty pharmaceutical,company, ... Food and Drug,Administration (FDA) product approval at its Goa, ... to seek FDA approval to,manufacture additional solid dosage products ... expected to be producing over 1 billion tablets,and capsules ...
... Stahl Cowen Crowley LLC, of Chicago,IL, counsel to ... that Dana Corporation, Inc. has entered into a settlement,agreement ... to,benefits. Dana had sought Bankruptcy Court approval to terminate ... result of the settlement Stahl,Cowen Crowley negotiated on behalf ...
... Brings Over 20 Years Of Experience ... in Sales, Marketing And Operational Excellence, LENEXA, Kan., ... ) announced the appointment of Thomas Kelly,Mann as chief ... than 20 years with 3M,s healthcare information technology,division where ...
... PICK: Immunosuppressive drugs are a double-edged sword to type ... caused when immune cells attack and destroy the insulin ... changed the life of type I diabetics, they neither ... was hoped that islet transplantation would provide a cure, ...
Cached Medicine News:Health News:Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve 2Health News:Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve 3Health News:Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve 4Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility 2Health News:Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee 2Health News:Mediware Names Thomas K. Mann Chief Executive Officer 2Health News:JCI table of contents: Sept. 4, 2007 2Health News:JCI table of contents: Sept. 4, 2007 3Health News:JCI table of contents: Sept. 4, 2007 4Health News:JCI table of contents: Sept. 4, 2007 5Health News:JCI table of contents: Sept. 4, 2007 6Health News:JCI table of contents: Sept. 4, 2007 7Health News:JCI table of contents: Sept. 4, 2007 8Health News:JCI table of contents: Sept. 4, 2007 9Health News:JCI table of contents: Sept. 4, 2007 10Health News:JCI table of contents: Sept. 4, 2007 11Health News:JCI table of contents: Sept. 4, 2007 12
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
Medicine Products: